These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Endocrine response following burns. Levels of some hormones (author's transl)]. Dolecek R; Adámková M; Leikep K; Sotorníková T; Závada M Cas Lek Cesk; 1977 Jun; 116(24):743-7. PubMed ID: 884698 [No Abstract] [Full Text] [Related]
7. Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation. Felt V; Nedvídková J Endokrinologie; 1982 Oct; 80(2):201-6. PubMed ID: 6819130 [No Abstract] [Full Text] [Related]
8. Hormonal changes in patients with haematological malignancies. Pavelic K; Pekic B; Gabrilovac J; Bratic-Mikes V; Boranic M Biomedicine; 1981 Nov; 35(6):181-4. PubMed ID: 6279194 [TBL] [Abstract][Full Text] [Related]
9. [Growth hormone secretion in relation to changes in thyrotropic hormone after thyroliberin in patients with acromegaly and dopaminergic stimulation (author's transl)]. Felt V; Nedvídková J Cas Lek Cesk; 1982 Apr; 121(16):489-93. PubMed ID: 6807547 [No Abstract] [Full Text] [Related]
10. [Concentration of pituitary-thyroid system hormones in the blood of patients with chronic circulatory insufficiency]. Aleksandrova TN; Naumov VG; Lobova NM; Masenko VP; Zyrianov AM Vestn Akad Med Nauk SSSR; 1984; (2):62-5. PubMed ID: 6711111 [No Abstract] [Full Text] [Related]
11. [Influence of hemodialysis on hormone status of terminal kidney failured patients]. Bindeballe W; Leybold K; Niedermayer W; Schaper H; Schemmel K; Weisbecker L Verh Dtsch Ges Inn Med; 1973; 79():1249-52. PubMed ID: 4790149 [No Abstract] [Full Text] [Related]
12. [Basal levels of somatotropin, cortisol and insulin in patients with chronic forms of ischemic heart disease]. Fitilev SB; Saprygin DB; Migalina LA; Besshapov EP Klin Med (Mosk); 1985 Oct; 63(10):106-10. PubMed ID: 3908793 [No Abstract] [Full Text] [Related]
13. [Levels of cortisol, immunoreactive insulin and somatotropic hormone in the blood of patients with chronic ischemic heart disease]. Volkov VI; Tseluĭko VI; Simirenko LL; Volodos' NL Vrach Delo; 1987 Nov; (11):21-3. PubMed ID: 3326272 [No Abstract] [Full Text] [Related]
14. [Investigations concerning the effect of synthetic "thyrotropin releasing factor" (TRF) in patients with thyroid gland function disorders and in healthy controls]. zur Mühlen A von ; Köbberling J; Hesch RD; Emrich D Acta Endocrinol Suppl (Copenh); 1971; 152():76. PubMed ID: 4101597 [No Abstract] [Full Text] [Related]
15. [Hormone determination with the radio-immunologic method]. Verdy M Union Med Can; 1971 Nov; 100(11):2232-6. PubMed ID: 4338734 [No Abstract] [Full Text] [Related]
16. [Relations between insulin, growth hormone and hyperlipoproteinemia in chronic kidney failure]. Sorge F; Schwartzkopff W; Castro LA; Kessel M; Nagel A; Hoffmann H Verh Dtsch Ges Inn Med; 1972; 78():1472-6. PubMed ID: 4665586 [No Abstract] [Full Text] [Related]
17. Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease. Donaghy A; Ross R; Gimson A; Hughes SC; Holly J; Williams R Hepatology; 1995 Mar; 21(3):680-8. PubMed ID: 7533122 [TBL] [Abstract][Full Text] [Related]